Credit Suisse’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.72M | Sell |
|
|||||
|
2023
Q4 | $64.2M | Buy |
|
|||||
|
2023
Q3 | $43.4M | Sell |
|
|||||
|
2023
Q2 | $61.7M | Buy |
|
|||||
|
2023
Q1 | $54.4M | Sell |
|
|||||
|
2022
Q4 | $64.4M | Buy |
|
|||||
|
2022
Q3 | $48.1M | Buy |
|
|||||
|
2022
Q2 | $51M | Sell |
|
|||||
|
2022
Q1 | $56.2M | Sell |
|
|||||
|
2021
Q4 | $53.9M | Sell |
|
|||||
|
2021
Q3 | $60.7M | Buy |
|
|||||
|
2021
Q2 | $52.2M | Buy |
|
|||||
|
2021
Q1 | $41.5M | Sell |
|
|||||
|
2020
Q4 | $43.6M | Buy |
|
|||||
|
2020
Q3 | $32.9M | Sell |
|
|||||
|
2020
Q2 | $38.2M | Buy |
|
|||||
|
2020
Q1 | $34.6M | Buy |
|
|||||
|
2019
Q4 | $40.8M | Sell |
|
|||||
|
2019
Q3 | $28.4M | Buy |
|
|||||
|
2019
Q2 | $21M | Buy |
|
|||||
|
2019
Q1 | $21.6M | Buy |
|
|||||
|
2018
Q4 | $16.5M | Buy |
|
|||||
|
2018
Q3 | $25.4M | Buy |
|
|||||
|
2018
Q2 | $25.1M | Sell |
|
|||||
|
2018
Q1 | $23.9M | Sell |
|
|||||
|
2017
Q4 | $23.5M | Sell |
|
|||||
|
2017
Q3 | $24.8M | Buy |
|
|||||
|
2017
Q2 | $25.4M | Sell |
|
|||||
|
2017
Q1 | $24.9M | Sell |
|
|||||
|
2016
Q4 | $23.8M | Buy |
|
|||||
|
2016
Q3 | $23.5M | Sell |
|
|||||
|
2016
Q2 | $20.7M | Buy |
|
|||||
|
2016
Q1 | $17.3M | Buy |
|
|||||
|
2015
Q4 | $16.9M | Buy |
|
|||||
|
2015
Q3 | $15M | Sell |
|
|||||
|
2015
Q2 | $17.4M | Buy |
|
|||||
|
2015
Q1 | $1.79M | Sell |
|
|||||
|
2014
Q4 | $1.78M | Buy |
|
|||||
|
2014
Q3 | $866K | Sell |
|
|||||
|
2014
Q2 | $10.1M | Buy |
|
|||||
|
2014
Q1 | $1.38M | Sell |
|
|||||
|
2013
Q4 | $1.49M | Buy |
|
|||||
|
2013
Q3 | $529K | Sell |
|
|||||
|
2013
Q2 | $1.06M | Buy |
|